These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 11033476)

  • 1. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
    Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
    Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome?
    Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC
    Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of livedoid vasculopathy in a 22-year-old man.
    Leonard A; Pomeranz MK; Franks AG
    J Drugs Dermatol; 2004; 3(6):678-9. PubMed ID: 15624752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?
    Acland KM; Darvay A; Wakelin SH; Russell-Jones R
    Br J Dermatol; 1999 Jan; 140(1):131-5. PubMed ID: 10215783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
    Hairston BR; Davis MD; Pittelkow MR; Ahmed I
    Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Livedoid vasculitis in a patient with antiphospholipid syndrome].
    Serra S; Saavedra MJ; Salvador MJ; Reis JP; Malcata A
    Acta Reumatol Port; 2010; 35(2):249-53. PubMed ID: 20711098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
    Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
    Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
    Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
    Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Idiopathic" white atrophy].
    Tran MD; Bécherel PA; Cordel N; Piette JC; Francès C
    Ann Dermatol Venereol; 2001 Oct; 128(10 Pt 1):1003-7. PubMed ID: 11907958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
    Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livedoid vasculopathy: A review of pathogenesis and principles of management.
    Vasudevan B; Neema S; Verma R
    Indian J Dermatol Venereol Leprol; 2016; 82(5):478-88. PubMed ID: 27297279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
    Di Giacomo TB; Hussein TP; Souza DG; Criado PR
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiphospholipid antibody syndrome as the cause of clinical rapidly progressing vasculopathy].
    Henning BF; Büchner N; Kirchner J; Gillessen A
    Dtsch Med Wochenschr; 2000 May; 125(19):589-93. PubMed ID: 11320717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
    Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
    Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livedoid vasculopathy associated with heterozygous protein C deficiency.
    Boyvat A; Kundakçi N; Babikir MO; Gürgey E
    Br J Dermatol; 2000 Oct; 143(4):840-2. PubMed ID: 11069468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.